Abstract Details

Title Multimodal EPs predict no evidence of disease activity at two years of first line multiple sclerosis treatment

Topic Multiple Sclerosis

Presentation(s) P4 - (-)

Poster/Presentation
Number 386

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Letizia M. Leocani, MD (University Vita-Salute San Raffaele, INSPE) PRESENTER	Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Marco Pisa, MD (Nuffield Department of Clinical Neurosciences, University of Oxford)	Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Lucia Moiola, MD, PhD (Fondazione Centro San Raffaele)	Dr. Moiola has nothing to disclose.
Vittorio Martinelli (S. Raffaele Hospital)	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
	No disclosure on file